Your browser is no longer supported. Please, upgrade your browser.
BIO-B Bio-Rad Laboratories, Inc. daily Stock Chart
Bio-Rad Laboratories, Inc.
Index- P/E30.31 EPS (ttm)12.48 Insider Own- Shs Outstand5.10M Perf Week2.07%
Market Cap1.93B Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month16.87%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter61.69%
Sales2.30B P/S0.84 EPS this Y- Inst Trans- Short Ratio0.00 Perf Half Y75.77%
Book/sh171.41 P/B2.21 EPS next Y- ROA- Target Price- Perf Year215.29%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range238.07 - 383.66 Perf YTD2.37%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-1.38% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low58.92% ATR4.85
Employees8000 Current Ratio- Sales Q/Q2.80% Oper. Margin- RSI (14)65.36 Volatility0.00% 0.38%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.00 Prev Close375.44
ShortableNo LT Debt/Eq- EarningsJan 30 BMO Payout- Avg Volume1.90K Price378.35
Recom- SMA203.78% SMA5011.66% SMA20049.72% Volume2 Change0.78%
Jan-09-20 05:40AM  Is Bio-Rad Laboratories, Inc.'s (NYSE:BIO) ROE Of 7.3% Concerning? Simply Wall St.
Jan-06-20 08:30AM  Bio-Rad Appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President Business Wire
Jan-02-20 04:15PM  Bio-Rad to Participate at the 38th Annual J.P. Morgan Healthcare Conference on January 13 Business Wire
Dec-25-19 02:35PM  Bio-Rad Laboratories, Inc. (BIO) vs. Top 20 Hedge Fund Stocks in 2019 Insider Monkey
Dec-23-19 08:30AM  The International Trade Commission Issues Final Decision Affirming 10X Genomics Infringement of Three of Bio-Rads Patents Business Wire
Dec-13-19 04:52PM  Bio-Rad Makes Progress Recovering from Recent Ransomware Attack Business Wire
Dec-11-19 05:23AM  Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching Simply Wall St.
Nov-30-19 02:28PM  Hedge Funds Have Never Been This Bullish On Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Nov-11-19 07:49AM  Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? Simply Wall St.
Oct-31-19 04:15PM  Bio-Rad Reports Third-Quarter 2019 Financial Results Business Wire
Oct-29-19 05:09PM  This Hedge Fund Can Still Deliver Double Digit Returns: Here Are Its Top Picks Insider Monkey
Oct-23-19 11:13AM  5 Companies Hit 52-Week Highs
Oct-16-19 04:15PM  Bio-Rad to Report Third-Quarter 2019 Financial Results Thursday, October 31, 2019 Business Wire
Oct-15-19 12:05PM  5 Stocks to Buy in the Mighty Middle InvestorPlace
Oct-12-19 03:34PM  Heres What Hedge Funds Think About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Oct-01-19 05:10PM  It's not just Google: 'Fierce' competition for tech talent is pushing median salaries past $200K at many Silicon Valley companies American City Business Journals
Sep-18-19 09:07AM  Goldman Sachs: 4 Conviction Buy Stocks To Snap Up Now TipRanks
Sep-12-19 05:28PM  After record IPO, East Bay company's CEO targets growth and sleep American City Business Journals
09:55AM  On eve of biggest biotech IPO this year, 2 East Bay companies spar over patents American City Business Journals
Sep-11-19 05:48PM  Bio-Rad Files New Lawsuit Against 10X Genomics for Patent Infringement Business Wire
Aug-21-19 06:56PM  Fitch Ratings Upgrades Bio-Rad to BBB, Outlook Stable, Reflecting Continued Improvement in the Companys Operating Performance Business Wire
Aug-19-19 05:45PM  How a biotech revolution catapulted this East Bay company to a $100M IPO American City Business Journals
Aug-13-19 07:00AM  The $200K Club: NetApp's median employee gets a pay boost to join the salary ranks of Google, Netflix and Facebook American City Business Journals
Aug-01-19 08:26PM  Bio-Rad Laboratories Inc (BIO) (BIO-B) Q2 2019 Earnings Call Transcript Motley Fool -5.16%
04:15PM  Bio-Rad Reports Second-Quarter 2019 Financial Results Business Wire
Jul-24-19 09:52PM  Delaware District Court Grants Bio-Rads Motion for Permanent Injunction Against 10X Genomics Business Wire
Jul-23-19 08:46PM  Bio-Rad to Report Second-Quarter 2019 Financial Results Business Wire
Jul-08-19 07:30AM  Facebook churns out a per-employee profit of $635K per year. How that compares with Apple, Google, Cisco, Oracle, Salesforce and others American City Business Journals
Jul-01-19 05:43PM  Bio-Rad Laboratories, Inc. -- Moody's announces completion of a periodic review of ratings of Bio-Rad Laboratories, Inc. Moody's
Jun-27-19 07:34PM  Moodys Upgrades Bio-Rad to Baa2, Reflecting Recent Improvement in the Companys Operating Performance Business Wire
03:35PM  Bio-Rad Laboratories, Inc. -- Moody's upgrades Bio-Rad to Baa2, outlook is stable Moody's
Jun-14-19 08:29AM  Heres What Hedge Funds Think About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Jun-12-19 07:30AM  9 major Bay Area tech employers pay a typical worker more than $200K per year American City Business Journals
Jun-03-19 02:03PM  Bio-Rad to Participate in Goldman Sachs Annual Global Healthcare Conference on June 11 Business Wire
May-23-19 04:09PM  Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4 Business Wire
May-08-19 08:23PM  Bio-Rad Laboratories Inc (BIO) Q1 2019 Earnings Call Transcript Motley Fool
06:00PM  Bio-Rad: 1Q Earnings Snapshot Associated Press
04:15PM  Bio-Rad Reports First Quarter 2019 Financial Results Business Wire
May-07-19 07:30AM  Netflix and Google now pay a typical employee more than $200K per year. Here's how that compares to Facebook, Intel, Twitter and other big Bay Area tech employers. American City Business Journals
Apr-23-19 04:15PM  Bio-Rad to Participate in the Bank of America Merrill Lynch Health Care Conference 2019 in May Business Wire
Apr-22-19 05:00PM  Bio-Rad Appoints Andrew Last as Executive Vice President and Chief Operating Officer Business Wire
Apr-20-19 01:02PM  Is Bio-Rad Laboratories, Inc. (BIO) A Good Stock To Buy? Insider Monkey
Apr-15-19 07:03PM  Bio-Rad to Report First-Quarter 2019 Financial Results Business Wire
Apr-10-19 07:25AM  FireEye joins major Bay Area employers like Facebook, Netflix, Google, Microsoft and Salesforce in paying a typical worker more than $150,000 per year American City Business Journals
Apr-09-19 07:30AM  Dow Jones Futures: Zogenix Leads 3 Big Movers On FDA News Investor's Business Daily
Apr-08-19 04:15PM  Bio-Rad Receives U.S. FDA Clearance for the IH-500, Expanding Its Offering for the Blood Testing Market Business Wire
Apr-02-19 05:00PM  Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer Business Wire
08:30AM  Bio-Rad Announces Innovative Test to Aid in the Diagnosis of Lyme Disease with the FDA Clearance of the BioPlex 2200 Lyme Total Assay Business Wire
Mar-27-19 07:25AM  Recent Analysis Shows Transocean, Chipotle Mexican Grill, Marathon Oil, Laboratory Corporation of America, Bio-Rad Laboratories, and Graco Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Mar-25-19 05:00PM  Bio-Rad Laboratories, Inc. Receives Expected NYSE Notice Regarding Late Form 10-K Filing Business Wire
Feb-28-19 04:38PM  Bio-Rad Reports Fourth-Quarter and Full-Year 2018 Financial Results Business Wire
Feb-15-19 07:30AM  The typical Facebook employee earns double Silicon Valley's median household income. How 50+ big tech employers compare American City Business Journals
Feb-14-19 07:28PM  Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response Business Wire
Feb-12-19 06:31PM  Bio-Rad to Report Fourth-Quarter and Full-Year 2018 Financial Results Thursday, February 28, 2019 Business Wire
Feb-04-19 07:50AM  Report: Developing Opportunities within T-Mobile US, Noble, Akebia Therapeutics, Vornado Realty Trust, Bio-Rad Laboratories, and Standex International Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-15-19 07:30AM  This is how much Apple pays a typical employee and how that compares to Google, Facebook, Netflix, Microsoft, Box and more American City Business Journals
Jan-03-19 04:30PM  Christine Tsingos Announces Plans to Retire as CFO of Bio-Rad Laboratories, Inc. Effective April 30, 2019 Business Wire
Jan-02-19 06:10PM  Bio-Rad to Participate at the 37th Annual J.P. Morgan Healthcare Conference on January 8 Business Wire
Dec-09-18 03:00AM  Hedge Funds Are Crazy About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Dec-03-18 08:30AM  Bio-Rad Quality Controls Now Available for Multiple Abbott Clinical Diagnostics Platforms Business Wire
Nov-30-18 08:25AM  New Research Coverage Highlights Omeros, Apple, Bio-Rad Laboratories, Cott, Darling Ingredients, and Osisko Gold Royalties Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-14-18 08:55AM  Bio-Rad Clinches USDA Contract, Boosts Life Science Segment Zacks
08:30AM  Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies Business Wire
Nov-13-18 08:30AM  Bio-Rad Wins USDA Contract for Its Pathogen Detection Testing Products Business Wire
Nov-02-18 10:50AM  Bio-Rad (BIO) Earnings Miss Estimates in Q3, Revenues Beat Zacks
05:12AM  Bio-Rad: 3Q Earnings Snapshot Associated Press
Nov-01-18 09:25PM  Bio-Rad Laboratories Inc (BIO) Q3 2018 Earnings Conference Call Transcript Motley Fool
09:00PM  Bio-Rad Laboratories (BIO) Q3 Earnings Lag Estimates Zacks
07:54PM  Bio-Rad: 3Q Earnings Snapshot Associated Press
04:30PM  Bio-Rad Reports Third-Quarter 2018 Financial Results Business Wire
08:05AM  Boasting A 22% Return On Equity, Is Bio-Rad Laboratories Inc (NYSE:BIO) A Top Quality Stock? Simply Wall St.
Oct-29-18 08:30AM  Bio-Rad Receives U.S. FDA Clearance for the IH-Reader 24, Expanding the Companys Offering for the Blood Typing Market Business Wire
Oct-23-18 09:56AM  Leaning on tech expertise, Peninsula gene-editing company raises $110 million, targets lower-priced drugs American City Business Journals -8.79%
07:20AM  Research Report Identifies Nordson, Willis Towers Watson Public, Bio-Rad Laboratories, Insperity, SAP SE, and Wesco Aircraft with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Oct-16-18 10:47AM  What's in Store for Cerner (CERN) This Earnings Season? Zacks
Oct-09-18 12:00PM  Bio-Rad to Report Third-Quarter 2018 Financial Results Thursday, November 1, 2018 Business Wire
Sep-14-18 10:09AM  What You Must Know About Bio-Rad Laboratories Incs (NYSE:BIO) Financial Health Simply Wall St.
Sep-06-18 10:15AM  Bio-Rad (BIO) Down 0.3% Since Last Earnings Report: Can It Rebound? Zacks
Aug-29-18 07:27PM  Bio-Rad to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference on September 12 Business Wire
Aug-24-18 04:23AM  Here's Why You Should Steer Clear of AmerisourceBergen Now (Revised) Zacks
Aug-14-18 10:16AM  Bio-Rad (BIO) Banks on Blood Typing Market Amid Margin Woes Zacks
Aug-09-18 09:09AM  Bio-Rad (BIO) Tops Earnings and Revenue Estimates in Q2 Zacks
Aug-07-18 08:20PM  Bio-Rad Laboratories (BIO) Beats Q2 Earnings and Revenue Estimates Zacks
07:20PM  Bio-Rad: 2Q Earnings Snapshot Associated Press
04:49PM  Bio-Rad Reports Second-Quarter 2018 Financial Results Business Wire
03:00PM  Bio-Rad Laboratories, Inc. Class A to Host Earnings Call ACCESSWIRE
Jul-26-18 07:16AM  Get Sweet Surprise on Earnings From 5 Top-Ranked Stocks Zacks
Jul-25-18 07:45AM  Report: Developing Opportunities within Acxiom, BofI Holding, On Assignment, Marriot Vacations Worldwide, Bio-Rad Laboratories, and Dime Community Bancshares Future Expectations, Projections Moving into 2018 GlobeNewswire
Jul-16-18 01:49PM  Bio-Rad to Report Second-Quarter 2018 Financial Results Tuesday, August 7, 2018 Business Wire
Jul-12-18 09:30AM  Is Bio-Rad Laboratories (BIO) Outperforming Other Medical Stocks This Year? Zacks
Jul-06-18 09:36AM  Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Jul-05-18 03:17PM  Here's Why You Should Invest in Baxter (BAX) Stock Right Now Zacks
Jul-03-18 01:30PM  Bio-Rad Laboratories, Inc. -- Moody's affirms Bio-Rad's Baa3 senior unsecured rating; changes outlook to positive from stable Moody's
Jun-25-18 08:00AM  Is Bio-Rad Laboratories Inc (NYSE:BIO) A Buy At Its Current PE Ratio? Simply Wall St.
Jun-08-18 09:14AM  Bio-Rad Banks on Solid Global Scenario, Competition Rife Zacks
Jun-05-18 07:10AM  Wired News - LabCorp Collaborates with Unilabs to Expand Development and Reach of Precision Medicine Capabilities ACCESSWIRE
May-30-18 08:02PM  Bio-Rad to Present at Jefferies 2018 Global Healthcare Conference on June 5 Business Wire
May-29-18 09:58AM  Bio-Rad (BIO) Up 13.5% in 3 Weeks Post Solid Q1 Earnings Zacks
Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.